Looking into the IL-1 of the storm: are inflammasomes the link between immunothrombosis and hyperinflammation in cytokine storm syndromes?
Discovery Immunology · 2022
DOI: 10.1093/discim/kyac005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Discovery Immunology, 2022. Verfasst von Tara A Gleeson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Mancheste…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, University of Manchester.
Abstract (Originalsprache)
Inflammasomes and the interleukin (IL)-1 family of cytokines are key mediators of both inflammation and immunothrombosis. Inflammasomes are responsible for the release of the pro-inflammatory cytokines IL-1β and IL-18, as well as releasing tissue factor (TF), a pivotal initiator of the extrinsic coagulation cascade. Uncontrolled production of inflammatory cytokines results in what is known as a “cytokine storm” leading to hyperinflammatory disease. Cytokine storms can complicate a variety of diseases and results in hypercytokinemia, coagulopathies, tissue damage, multiorgan failure, and death. Patients presenting with cytokine storm syndromes have a high mortality rate, driven in part by disseminated intravascular coagulation (DIC). While our knowledge on the factors propagating cytokine storms is increasing, how cytokine storm influences DIC remains unknown, and therefore treatments for diseases, where these aspects are a key feature are limited, with most targeting specific cytokines. Currently, no therapies target the immunothrombosis aspect of hyperinflammatory syndromes. Here we discuss how targeting the inflammasome and pyroptosis may be a novel therapeutic strategy for the treatment of hyperinflammation and its associated pathologies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- Geoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester, UK.
- Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
- Swedish Orphan Biovitrum AB, Stockholm 112 76, Sweden.
ORCID-Profile: Jack P Green
Förderung
- Medical Research Council
- University of Manchester
Zitieren
APA
Gleeson, T. A., Nordling, E., Kaiser, C., Lawrence, C. B., Brough, D., Green, J. P., & Allan, S. M. (2022). Looking into the IL-1 of the storm: are inflammasomes the link between immunothrombosis and hyperinflammation in cytokine storm syndromes?. Discovery Immunology. https://doi.org/10.1093/discim/kyac005
Vancouver
Gleeson TA, Nordling E, Kaiser C, Lawrence CB, Brough D, Green JP, et al. Looking into the IL-1 of the storm: are inflammasomes the link between immunothrombosis and hyperinflammation in cytokine storm syndromes?. Discovery Immunology. 2022. doi:10.1093/discim/kyac005
BibTeX
@article{Gleeson2022,
author = {Gleeson, Tara A and Nordling, Erik and Kaiser, Christina and Lawrence, Catherine B and Brough, David and Green, Jack P and Allan, Stuart M},
title = {Looking into the IL-1 of the storm: are inflammasomes the link between immunothrombosis and hyperinflammation in cytokine storm syndromes?},
journal = {Discovery Immunology},
year = {2022},
doi = {10.1093/discim/kyac005}
}
EUVIMED